Braun Stacey Associates’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-75,507
Closed -$7.88M 143
2017
Q4
$7.88M Sell
75,507
-6,906
-8% -$779K 0.53% 89
2017
Q3
$12M Buy
82,413
+28,042
+52% +$3.82M 0.82% 71
2017
Q2
$7.06M Buy
54,371
+13,201
+32% +$1.62M 0.46% 93
2017
Q1
$5.12M Buy
41,170
+9,490
+30% +$1.14M 0.33% 99
2016
Q4
$3.67M Buy
31,680
+4,680
+17% +$521K 0.24% 113
2016
Q3
$2.82M Sell
27,000
-183
-0.7% -$19.8K 0.18% 109
2016
Q2
$2.68M Sell
27,183
-10
-0% -$1.03K 0.17% 106
2016
Q1
$2.72M Sell
27,193
-418
-2% -$43K 0.18% 107
2015
Q4
$3.31M Buy
27,611
+5,400
+24% +$625K 0.21% 101
2015
Q3
$2.4M Sell
22,211
-63,670
-74% -$7.9M 0.16% 102
2015
Q2
$9.94M Buy
85,881
+65,680
+325% +$7.51M 0.42% 98
2015
Q1
$2.33M Buy
20,201
+3,550
+21% +$424K 0.14% 104
2014
Q4
$1.86M Sell
16,651
-1,380
-8% -$146K 0.11% 103
2014
Q3
$1.71M Sell
18,031
-3,865
-18% -$349K 0.11% 108
2014
Q2
$1.88M Sell
21,896
-17,116
-44% -$1.3M 0.11% 108
2014
Q1
$2.72M Sell
39,012
-25,804
-40% -$2.04M 0.16% 105
2013
Q4
$5.48M Sell
64,816
-5,164
-7% -$409K 0.31% 100
2013
Q3
$5.39M Buy
69,980
+1,240
+2% +$86.9K 0.33% 96
2013
Q2
$4.02M Buy
+68,740
New +$4.14M 0.25% 102

Other funds holding CELG

Braun Stacey Associates's CELG Position: Q1 2018 in Review

Braun Stacey Associates sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 75,507 shares — an estimated $7.88M sold.

Braun Stacey Associates first reported a position in CELG in Q2 2013 and held it in 19 quarters. The position peaked at $12M in Q3 2017. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

  • Braun Stacey Associates reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
  • Braun Stacey Associates sold 75,507 Celgene Corp shares in Q1 2018, an estimated $7.88M.
  • Braun Stacey Associates first reported a position in Celgene Corp in Q2 2013 and held it in 19 quarters.
  • Braun Stacey Associates's Celgene Corp position peaked at $12M in Q3 2017.
  • 1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Braun Stacey Associates's 13F filing for Q1 2018, filed 1 May 2018.